Christopher Paul Fox

27PUBLICATIONS
148CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMetabolic medicineEpidemiological methodsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Apr 22, 2026
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

|Dec 22, 2025
Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study.

Joanna A Krupka, Ilias Moutsopoulos, Natasha H Cutmore

|Nov 21, 2025
Cost-effectiveness of risk-stratified blood test monitoring strategies for adults with inflammatory conditions.

Matt Stevenson, Georgina Nakafero, Hywel C Williams

|Oct 17, 2024
Real-world outcomes of patients with relapsed/refractory large B-cell lymphoma receiving second-line therapy in England.

Christopher P Fox, William Townsend, John G Gribben

|Oct 02, 2024
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment.

Stefan S Bielack, Carole Soussain, Christopher P Fox

Pageof 5

Frequent Collaborators

9 joint publications

Toby A Eyre

8 joint publications

Pamela McKay

6 joint publications

Nicolás Martínez-Calle

5 joint publications

Matthew J Ahearne